This is a preview of subscription content, log in via an institution to check access.
Notes
2011 Canadian dollars
Reference
Habib MJ, et al. Pharmacoeconomic evaluation of denosumab for the treatment of bone metastases in patients with advanced breast cancer in Canada. 36th Annual San Antonio Breast Cancer Symposium : abstr. P6-07-02, 10 Dec 2013. Available from: URL: http://www.abstracts2view.com/sabcs13/view.php?nu=SABCS13L_992
Rights and permissions
About this article
Cite this article
Denosumab dominates in SRE management. PharmacoEcon Outcomes News 695, 4 (2014). https://doi.org/10.1007/s40274-014-0995-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-0995-8